Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (359)
Reports (1)
SAGE documentation (34)
Scientific publications (4)
Systematic reviews (SYSVAC) (1190)
Regions
Africa (62)
Americas (192)
Eastern Mediterranean (12)
Europe (160)
Global (1)
South-East Asia (11)
Western Pacific (39)
Diseases
COVID-19 (1589)
Chikungunya (13)
Cholera (35)
Cytomegalovirus (1)
Dengue (43)
Diphtheria (90)
Ebola (19)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (171)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (77)
HIV / AIDS (10)
Human papillomavirus (HPV) (537)
Influenza (629)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (33)
Measles (144)
Meningococcal disease (155)
Moraxella catarrhalis (1)
Mpox (58)
Mumps (50)
Pertussis (120)
Pneumococcal disease (305)
Poliomyelitis (94)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (69)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (14)
Tuberculosis (83)
Typhoid (32)
Varicella (77)
Yellow fever (44)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (13)
Moderate (9)
Low (130)
Critically low (729)
Not applicable (309)
1589 results found
2020
∙
ACIP
COVID-19 vaccine prioritization: Work Group considerations
2020
∙
ACIP, Grace M Lee
COVID-19 Vaccine Safety
2020
∙
ACIP
COVID-19 Vaccine Safety Considerations
2020
∙
ACIP, Tom Shimabukuro
COVID-19 vaccine safety monitoring
2020
∙
ACIP
COVID-19 vaccine Work Group Considerations: Evidence to Recommendation Framework
2020
∙
Kathleen Dooling, ACIP
COVID-19 vaccines: Policy Questions, Evidence to Recommendation Framework & Critical and Important Outcomes
2020
∙
Sara Oliver, ACIP
COVID-19 vaccines: Work Group interpretations
2020
∙
Megan Wallace, ACIP
Disparities in COVID-19 Incidence, Severity, and Outcomes
2020
∙
Tom Shimabukuro, ACIP
Enhanced safety monitoring for COVID-19 vaccines in early phase vaccination
2020
∙
ACIP
Epidemiology of COVID-19 in Essential Workers, including Healthcare Personnel
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
